WHY IT MATTERS: If you are buying hemp-derived CBD or delta-8 products at a gas station or retail store in Wisconsin, there is currently no reliable guarantee that what is on the label matches what is in the product, including the THC content. CLINICAL OVERVIEW: Hemp-derived products sold legally in retail settings are not subject to the same testing and labeling requirements as products sold through licensed cannabis dispensaries, creating a significant gap in consumer protection. When products contain more THC than disclosed or permitted, consumers have no reliable way to know what they are actually ingesting, which raises meaningful concerns about unintended intoxication, drug interactions, and impaired driving.
Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds
WHY IT MATTERS: Patients purchasing hemp-derived products in Alabama and other states with limited oversight may be unknowingly consuming products with inaccurate THC levels or harmful contaminants, which poses real risks to health and undermines therapeutic goals. CLINICAL OVERVIEW: Unregulated hemp-derived products have long occupied a legal gray zone where labeling claims frequently diverge from actual contents, and third-party testing has repeatedly revealed discrepancies in cannabinoid concentrations alongside contamination with mold, pesticides, and carcinogenic compounds. Alabama’s new THC limits for hemp products reflect a broader regulatory trend of states stepping in to fill the vacuum left by federal inaction on consumer safety standards for this category.
Many Hemp Intoxicants Contain THC, Synthetic Cannabinoids – NORML
WHY IT MATTERS: If you are currently using commercially available hemp-derived intoxicants such as delta-8 or delta-10 products, you may be consuming synthetic cannabinoids or illegal THC levels without any labeling disclosure to warn you. CLINICAL OVERVIEW: Unregulated intoxicating hemp products pose a serious public health concern because many contain delta-9 THC concentrations above the federal 0.3% legal threshold, effectively making them unregistered cannabis products sold without the consumer protections of a licensed dispensary system. More alarming is the presence of synthetic cannabinoids in a significant proportion of these products, compounds with unpredictable pharmacology, narrow safety margins, and no established therapeutic dosing data.
Are My THC Gummies Going Away? – Science Friday
WHY IT MATTERS: If federal law changes to restrict hemp-derived THC gummies and similar products, patients currently using them for pain, sleep, or anxiety may need to transition to state-regulated medical cannabis programs or lose access to their current therapies entirely. CLINICAL OVERVIEW: The legal status of THC gummies derived from hemp is under increasing scrutiny as federal lawmakers consider closing the loophole created by the 2018 Farm Bill that allowed hemp-derived THC products to flood the consumer market. From a clinical standpoint, many patients have come to rely on these accessible, legal THC products for symptom management, particularly in states without robust medical cannabis programs.